View in EDS

Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.

Saved in:
Bibliographic Details
Title: Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.
Authors: Morató X; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Puerta R; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Universitat de Barcelona (UB), Spain., Cano A; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, Spain., Orellana A; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., de Rojas I; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Capdevila M; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, Spain., Montrreal L; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., Rosende-Roca M; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., García-González P; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., Olivé C; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., García-Gutiérrez F; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., Blázquez J; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., Miguel A; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., Núñez-Llaves R; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., Pytel V; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., Alegret M; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Fernández MV; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain., Marquié M; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Valero S; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Cavazos JE; South Texas Medical Science Training Program, University of Texas Health San Antonio, San Antonio, TX, USA.; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA., Mañes S; Department of Immunology and Oncology, Centro Nacional Biotecnología (CNB-CSIC), 28049, Madrid, Spain., Boada M; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Cabrera-Socorro A; Neuroscience Therapeutic Area, Drug Discovery, Johnson & Johnson Innovative Medicine, USA., Ruiz A; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA.
Source: Brain, behavior, & immunity - health [Brain Behav Immun Health] 2024 Nov 16; Vol. 42, pp. 100899. Date of Electronic Publication: 2024 Nov 16 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101759062 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-3546 (Electronic) Linking ISSN: 26663546 NLM ISO Abbreviation: Brain Behav Immun Health Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39640195
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Morató+X%22">Morató X</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Puerta+R%22">Puerta R</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Universitat de Barcelona (UB), Spain.<br /><searchLink fieldCode="AU" term="%22Cano+A%22">Cano A</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Orellana+A%22">Orellana A</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22de+Rojas+I%22">de Rojas I</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Capdevila+M%22">Capdevila M</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Science, Universitat de Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Montrreal+L%22">Montrreal L</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rosende-Roca+M%22">Rosende-Roca M</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García-González+P%22">García-González P</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Olivé+C%22">Olivé C</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22García-Gutiérrez+F%22">García-Gutiérrez F</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Blázquez+J%22">Blázquez J</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Miguel+A%22">Miguel A</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Núñez-Llaves+R%22">Núñez-Llaves R</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Pytel+V%22">Pytel V</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Alegret+M%22">Alegret M</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fernández+MV%22">Fernández MV</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Marquié+M%22">Marquié M</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Valero+S%22">Valero S</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cavazos+JE%22">Cavazos JE</searchLink>; South Texas Medical Science Training Program, University of Texas Health San Antonio, San Antonio, TX, USA.; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Mañes+S%22">Mañes S</searchLink>; Department of Immunology and Oncology, Centro Nacional Biotecnología (CNB-CSIC), 28049, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Boada+M%22">Boada M</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Cabrera-Socorro+A%22">Cabrera-Socorro A</searchLink>; Neuroscience Therapeutic Area, Drug Discovery, Johnson & Johnson Innovative Medicine, USA.<br /><searchLink fieldCode="AU" term="%22Ruiz+A%22">Ruiz A</searchLink>; Ace Alzheimer Center Barcelona-Universitat Internacional de Catalunya, Barcelona, Spain.; Networking Research Center on Neurodegenerative Diseases (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.; Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center, San Antonio, TX, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101759062%22">Brain, behavior, & immunity - health</searchLink> [Brain Behav Immun Health] 2024 Nov 16; Vol. 42, pp. 100899. <i>Date of Electronic Publication: </i>2024 Nov 16 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101759062 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-3546 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226663546%22">26663546 </searchLink><i>NLM ISO Abbreviation: </i>Brain Behav Immun Health <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39640195
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.bbih.2024.100899
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100899
    Titles:
      – TitleFull: Associations of plasma SMOC1 and soluble IL6RA levels with the progression from mild cognitive impairment to dementia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Morató X
      – PersonEntity:
          Name:
            NameFull: Puerta R
      – PersonEntity:
          Name:
            NameFull: Cano A
      – PersonEntity:
          Name:
            NameFull: Orellana A
      – PersonEntity:
          Name:
            NameFull: de Rojas I
      – PersonEntity:
          Name:
            NameFull: Capdevila M
      – PersonEntity:
          Name:
            NameFull: Montrreal L
      – PersonEntity:
          Name:
            NameFull: Rosende-Roca M
      – PersonEntity:
          Name:
            NameFull: García-González P
      – PersonEntity:
          Name:
            NameFull: Olivé C
      – PersonEntity:
          Name:
            NameFull: García-Gutiérrez F
      – PersonEntity:
          Name:
            NameFull: Blázquez J
      – PersonEntity:
          Name:
            NameFull: Miguel A
      – PersonEntity:
          Name:
            NameFull: Núñez-Llaves R
      – PersonEntity:
          Name:
            NameFull: Pytel V
      – PersonEntity:
          Name:
            NameFull: Alegret M
      – PersonEntity:
          Name:
            NameFull: Fernández MV
      – PersonEntity:
          Name:
            NameFull: Marquié M
      – PersonEntity:
          Name:
            NameFull: Valero S
      – PersonEntity:
          Name:
            NameFull: Cavazos JE
      – PersonEntity:
          Name:
            NameFull: Mañes S
      – PersonEntity:
          Name:
            NameFull: Boada M
      – PersonEntity:
          Name:
            NameFull: Cabrera-Socorro A
      – PersonEntity:
          Name:
            NameFull: Ruiz A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 11
              Text: 2024 Nov 16
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2666-3546
          Numbering:
            – Type: volume
              Value: 42
          Titles:
            – TitleFull: Brain, behavior, & immunity - health
              Type: main
ResultId 1